Meeting
2015 Genitourinary Cancers Symposium
Association between a 17-gene genomic prostate score and multiparametric prostate MRI in men with low- and intermediate-risk prostate cancer (PCa).
Authors
Michael S. Leapman
University of California, San Francisco, San Francisco, CA
Michael S. Leapman , Antonio C. Westphalen , Niloufar Ameli , H. Jeffrey Lawrence , Phillip G. Febbo , Matthew R. Cooperberg , Peter Carroll
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 83)
DOI
10.1200/jco.2015.33.7_suppl.83
Abstract #
83
Poster Bd #
D24
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Genomic analysis for active surveillance to predict upstaging after prostatectomy.
First Author: Andrea Quinn
Poster
2016 Genitourinary Cancers Symposium
Change in a 17-gene genomic prostate score over time in men with low- and intermediate-risk prostate cancer managed with active surveillance.
First Author: Michael S. Leapman
Poster
2023 ASCO Genitourinary Cancers Symposium
Geographic variation of decipher genomic classifier in patients with early prostate cancer.
First Author: Daniel Keizman
Poster
2023 ASCO Genitourinary Cancers Symposium
The impact of genomic biomarkers on a validated clinical risk prediction model for upgrading/upstaging among men with low-risk prostate cancer.
First Author: Avery Braun